Verum.de CEO to Present on International Clinical Trial Regulations at BIOCOM Event - German-based CRO Verum educating US customers on changing trial regulations in Europe -
SAN DIEGO, Nov. 9, 2012 /PRNewswire/ -- The CEO of Verum.de (Verum), a full-clinical service, German-based contract research organization (CRO) with a new office in Carlsbad, Calif. will speak at an upcoming event held by BIOCOM, the large regional life science association, on Tuesday, Nov. 13, 2012 at 7:30 a.m. PST. The session, Legal and Regulatory Update - Health Care Reform and FDA Developments, will feature Verum CEO Christian Sacher presenting about the clinical trial approval process in the European Union and the proposed changes to the EU trial regulations.
Verum joined BIOCOM earlier this year to expand awareness of its flexible and responsive services and its ability to run clinical trial services with Western standards in Central and Eastern European countries (CEE) and former Soviet bloc countries. With more than 25 years experience running clinical trials in Eastern Europe, Sacher is considered a pioneer in the industry. He helped bring ethical committees and Western best practices to trials in the region.
"It is an honor to have the opportunity to speak at BIOCOM as the organization mirrors Verum's values regarding clinical trials," says Christian Sacher. "With both FDA and European regulations constantly changing, we need to help biotech, pharma and device companies stay on top of the latest developments."
Verum recently opened a U.S. office in Carlsbad to assist U.S. clients with international trials. The new office is headed by Kristi Clark, an industry veteran with more than 20 years of pharma and biotech experience in both large and mid-size CROs.
German-based Verum.de was founded by Christian Sacher and Jutta Minkner (CFO), two industry pioneers with more than 25 years experience running clinical trials in CEE and former Soviet bloc countries. Verum has more than 100 office based employees operating out of eight locations, including its Munich headquarters, and the company offers therapeutic specialties in cardiovascular, neurology, psychiatry, CNS, oncology and pain, among others. Verum started operations in 1992 in CEE countries based on Western ideals and ethical standards. Verum has substantial contacts with local authorities, and is known in CEE for the flexible and responsive services it provides. More information can be found at http://www.verum.de
Clearpoint Agency, for Verum.de